The European Commission to Buy 150 Million Moderna Vaccines Before 2022
The European Commission is buying 150 million extra doses of the Covid-19 vaccine from the American company Moderna on behalf of the EU countries.
The current contract will be adjusted before 2022 also to purchase vaccines that protect against new variants, which can be used in children, and ‘refreshment’ vaccines that can be given for extra protection after previous vaccinations.
According to the commission, the updated contract also guarantees on-time delivery of vaccines from the third quarter of this year until the end of 2022. In addition, it allows member states to have more or fewer deliveries depending on the epidemiological situation in the country.
They can also donate or resell their ordered doses to countries outside the EU, according to a statement from the EU’s executive board. The EU has already purchased more than 300 million doses of Moderna.
At the end of April, Brussels announced that its purchasing policy would mainly focus on vaccines that are produced using new technology, such as that of Pfizer/BioNTech and Moderna. The committee then also decided against purchasing additional doses of Janssen and AstraZeneca to which it was entitled.
There are ongoing problems with deliveries from the latter two pharmacies, while there are also concerns about side effects.